Giuseppe S. Alvaro
Founder at Autifony Therapeutics Ltd.
Profile
Giuseppe S.
Alvaro is the founder and the Chief Research Officer at Autifony Therapeutics Ltd., a company founded in 2011.
He previously worked as the Director & Chemistry Leader at GSK Plc.
Dr. Alvaro holds a doctorate degree from Alma Mater Studiorum - Università di Bologna.
Giuseppe S. Alvaro active positions
| Companies | Position | Start |
|---|---|---|
Autifony Therapeutics Ltd.
 Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Founder | 2011-08-23 |
Former positions of Giuseppe S. Alvaro
| Companies | Position | End |
|---|---|---|
| GSK PLC | Director/Board Member | - |
Training of Giuseppe S. Alvaro
| Alma Mater Studiorum - Università di Bologna | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GSK PLC | Health Technology |
| Private companies | 1 |
|---|---|
Autifony Therapeutics Ltd.
Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Giuseppe S. Alvaro
